Ergoteles’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-59,231
Closed -$1.13M 315
2023
Q2
$1.13M Buy
+59,231
New +$1.14M 0.05% 433
2023
Q1
Sell
-201,374
Closed -$3.23M 1405
2022
Q4
$3.23M Buy
201,374
+180,059
+845% +$2.94M 0.12% 175
2022
Q3
$334K Buy
21,315
+10,944
+106% +$211K 0.01% 932
2022
Q2
$216K Sell
10,371
-21,467
-67% -$442K 0.01% 1283
2022
Q1
$722K Sell
31,838
-33,100
-51% -$647K 0.03% 536
2021
Q4
$1.19M Buy
+64,938
New +$1.24M 0.05% 373

Other funds holding EXEL

Ergoteles's EXEL Position: Q3 2023 in Review

Ergoteles sold out of Exelixis (EXEL) in Q3 2023, closing a stake of 59,231 shares — an estimated $1.13M sold.

Ergoteles first reported a position in EXEL in Q4 2021 and held it in 6 quarters. The position peaked at $3.23M in Q4 2022. 397 funds tracked by Wall St. Rank hold EXEL as of Q3 2023.

  • Ergoteles reported no remaining Exelixis position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 59,231 Exelixis shares in Q3 2023, an estimated $1.13M.
  • Ergoteles first reported a position in Exelixis in Q4 2021 and held it in 6 quarters.
  • Ergoteles's Exelixis position peaked at $3.23M in Q4 2022.
  • 397 funds tracked by Wall St. Rank held Exelixis as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.